Obesity is a major risk factor for breast cancer. Many women avoid taking tamoxifen, a drug often prescribed to lower breast cancer risk, because of its unpleasant side effects. These can include hot flashes and other vasomotor symptoms, as well as issues with insulin resistance and high triglyceride levels, especially in women with obesity. This is where Bazedoxifene/Conjugated Estrogens (BZA/CE) comes in. It's a drug combination that can ease those vasomotor symptoms and is currently being tested to see if it can also lower breast cancer risk.

        Researchers wanted to see if BZA/CE could help with metabolic health, especially in women with obesity. They used a rat model to simulate breast cancer risk and fed some of the rats a high-fat diet to make them obese. They then gave some of these rats BZA/CE and others a placebo for eight weeks.

        The results were promising. BZA/CE helped reduce body fat and encouraged the growth of smaller, insulin-sensitive mammary fat cells. It also boosted the presence of beneficial gut bacteria, like Faecalbaculum rodentium and Odoribacter laneus. These bacteria are known to support better metabolic health. The treatment also reversed some of the negative effects of obesity on lipids and adipokines, which are hormones that regulate fat tissue.

        But the benefits didn't stop there. BZA/CE also seemed to reverse the overactivity of cell proliferation pathways in the mammary glands, which are often seen in obese individuals. This suggests that the treatment might help reduce the risk of breast cancer.

        So, what does all this mean? Well, it looks like BZA/CE could be a game-changer for women with obesity who are at high risk for breast cancer. It not only helps with those pesky side effects but also seems to improve metabolic health and potentially lower cancer risk.

        However, it's important to note that this study was conducted on rats and not humans. More research is needed to fully understand how BZA/CE might work in people. Also, the study didn't look at the long-term effects of BZA/CE, so it's hard to say how sustainable these benefits might be.

        In the meantime, it's clear that managing obesity is crucial for reducing breast cancer risk. Lifestyle changes, such as a healthy diet and regular exercise, can make a big difference. And for those who might benefit from medication, BZA/CE could be a promising option.

Can Bazedoxifene/Conjugated Estrogens Help Obese Women Fight Breast Cancer?

Actions